Ruth Alon

Ruth Alon is the founder of NetVision Ltd. (1993), Israel Advanced Technology Industries (2012), Israel Life Science Industry (2005), and Medstrada Ltd. (2016) as Chief Executive Officer & Director.
Ms. Alon is currently Chairman of TransPharma Medical Ltd., Chairman of BrainsGate Ltd. since 2000, Director of APOS Medical Israel Ltd., Director of CarboFix Orthopedics Ltd., Director of 330 Avenue Medical Health PC, Director of BioRap Technologies Ltd., Independent Director of Alpha Tau Medical Ltd. since 2022, Director of Treos Bio Ltd. since 2021, Director of Phoska Biopharma Pte Ltd., Independent Director of Silexion Therapeutics Corp.
starting in 2024, Independent Director of Moringa Acquisition Corp., and BRD of Fibronostics US, Inc. Former positions include Co-Chairman of Kadimastem Ltd. (2020-2021), Independent External Director of Anchiano Therapeutics Ltd., Director of HealOr Ltd., Director of Proneuron Biotechnologies, Inc., Independent Non-Executive Director of Vascular Biogenics Ltd. (2010-2023), Director of BlueTree Technologies Ltd. (2020-2022), Principal of Montgomery Securities, Inc., Principal of Kidder Peabody (1987-1993), and General Partner of Pitango Venture Capital (1997-2016).
Education includes an MBA from Boston University, an undergraduate degree from The Hebrew University of Jerusalem, and a graduate degree from Columbia University College of Physicians & Surgeons.